TXMD
NASD TherapeuticsMD, Inc.$2.02 ↑ +0.00 (+0.00%) Trading Up from the previous close of $2.02, $0.03 below the day’s high of $2.05
- YTD change
- +23.93%
- vs 20-day SMA
- -3.40%
- vs 200-day SMA
- -4.55%
Price ranges
Price & Performance
-0.03 (-1.46%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $4,500.00
- TXMD is up 24% since the beginning of the year
- TXMD is up 94% over the past 12 months
- TXMD is down 6% over the past 1 month
- 1% of all TXMD investors are betting against TXMD
TXMD reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is +92.4%.
- Previous minute
- +$0.00
- Last hour
- +$0.02
- Last 5 days
- -1.46%
- vs 8-day SMA
- -0.31%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
TherapeuticsMD, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of products for women. The firm's technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. It also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the BIJUVA, IMVEXXY, vitaMedMD and BocaGreenMD brands. The company was founded by Robert G. Finizio and Brian A. Bernick in 1907 and is headquartered in Boca Raton, FL.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
